{"id":495918,"date":"2026-06-12T11:12:08","date_gmt":"2026-06-12T11:12:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/495918\/"},"modified":"2026-06-12T11:12:08","modified_gmt":"2026-06-12T11:12:08","slug":"glucosamine-linked-to-25-faster-alzheimers-progression-in-major-new-study","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/495918\/","title":{"rendered":"Glucosamine linked to 25% faster Alzheimer&#8217;s progression in major new study"},"content":{"rendered":"<p>A new study published in <a href=\"https:\/\/www.nature.com\/articles\/s42255-026-01538-4\" rel=\"nofollow noopener\" target=\"_blank\">Nature Metabolism<\/a> has found that glucosamine is associated with a significantly faster progression from mild cognitive impairment (MCI) to Alzheimer&#8217;s disease.<\/p>\n<p>The ingredient is one of the most widely used dietary supplements globally, with the findings carrying substantial implications for nutraceutical manufacturers, brands and formulators operating in the joint health space.<\/p>\n<p>The study<\/p>\n<p>The University of Florida research found that glucosamine use is associated with a 25% higher likelihood that a person with MCI will progress to full Alzheimer&#8217;s disease.<\/p>\n<p>Among patients already diagnosed with Alzheimer&#8217;s disease and related dementias, glucosamine use was also associated with a 25% increase in mortality risk \u2014 though, this elevated risk was not observed in those at the MCI stage, suggesting the supplement&#8217;s effects may vary depending on disease progression.<\/p>\n<p>The study&#8217;s scope was extensive, with researchers analysing clinical records identifying more than\u00a050,000 patients\u00a0diagnosed with Alzheimer&#8217;s disease-related dementias.<\/p>\n<p>They then used physician notes and prescription records to identify patients with documented glucosamine use of at least one year following diagnosis.<\/p>\n<p>The study identifies hyperglycosylation\u00a0(an overactive protein sugar-tagging metabolic pathway) as a potential driver of Alzheimer&#8217;s disease and a promising therapeutic target. <\/p>\n<p>Glucosamine, as a sugar-related molecule, appears to feed directly into this dysfunctional pathway in susceptible brains.\u00a0<\/p>\n<p>Researchers noted that glucosamine can cross the blood-brain barrier, where it can contribute to biochemical pathways involved in building complex sugar structures on proteins. <\/p>\n<p>In a brain already exhibiting Alzheimer&#8217;s-related metabolic disruption, supplemental glucosamine could amplify the damage.<\/p>\n<p>&#8220;Our results suggest that altered metabolism is a significant contributor to Alzheimer&#8217;s progression and, in addition, addressing the metabolic defect could be an important complement to approaches focused on Alzheimer&#8217;s plaques and tangles,&#8221; said senior author Dr Ramon Sun, director of the Center for Advanced Spatial Biomolecule Research and associate director for innovation of UF&#8217;s McKnight Brain Institute.<\/p>\n<p>Mouse model experiments have also supported this hypothesis: animals receiving glucosamine showed worsening social memory deficits, which improved when the sugar-tagging process was chemically suppressed.<\/p>\n<p>However, the researchers were clear that causality has not been established and that clinical trials will be needed.<\/p>\n<p>Industry context<\/p>\n<p>The commercial stakes are significant. The global glucosamine supplements market was valued at approximately $3.8bn in 2025 and is projected to reach $6.2bn by 2033.<\/p>\n<p>Joint health is one of the most established and consumer-trusted categories in nutraceuticals.<\/p>\n<p>                                    Not yet a Subscriber?<\/p>\n<p>\n            This is a small extract of the full article which is available<br \/>\n            ONLY to premium content subscribers.<br \/>\n            Click below to get premium content on Nutraceutical Business Review.\n        <\/p>\n<p>                                    <a href=\"https:\/\/hpcimedia.com\/service\/signup-campaign\/NBRSub\" class=\"btn\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe now<\/a><\/p>\n<p>                            Already a subscriber?<br \/>\n                            <a href=\"https:\/\/nutraceuticalbusinessreview.com\/authentication?redirect=\/glucosamine-linked-25-faster-alzheimer-progression-study\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n                                                Sign in here.<br \/>\n                                            <\/a><\/p>\n<p>                                    <a data-unique-id=\"4141\" data-is-mobile=\"1\" rel=\"nofollow\" href=\"#\" data-url=\"\/banner-load\/3613\/21\/6\/4141\/352365237\"><img decoding=\"async\" alt=\"\" data-delay=\"0\" data-duration=\"10\" src=\"https:\/\/nutraceuticalbusinessreview.com\/banner-image\/4141.jpg\" bad-src=\"data:image\/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAIAAACQd1PeAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAAJcEhZcwAADsMAAA7DAcdvqGQAAAAMSURBVBhXY\/j\/\/z8ABf4C\/qc1gYQAAAAASUVORK5CYII=\"\/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"A new study published in Nature Metabolism has found that glucosamine is associated with a significantly faster progression&hellip;\n","protected":false},"author":2,"featured_media":495919,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-495918","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/495918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=495918"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/495918\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/495919"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=495918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=495918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=495918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}